Categories Respiratory diseases -Adelphi Values

Respiratory diseases

Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
Forster R, Ratcliffe A, Lewis M, Crossley A, Lopez Bastida J, Dunlop W
Eur J Health Econ (2018), 1-16. https://doi.org/10.1007/s10198-018-0974-2

Critical inhaler errors in asthma and COPD: A systematic review of impact on health economics
Usmani OS, Lavorini F, Marshall J, Dunlop W, Heron L, Farrington E, Dekhuijzen R
Respiratory Research 2018, 19:10

Cost-utility analysis of a novel breath-triggered aerosol inhaler which has been designed to reduce the critical handling error of insufficient inspiratory effort
Forster R, Ratcliffe A, Lewis M, Crossley A, Lopez Bastida J, Dunlop W
Poster presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 20th Annual European Congress, Glasgow, Scotland, 4-8 November 2017

Health-related quality of life in South African patients with pulmonary tuberculosis
Kastien-Hilka T, Rosenkranz B, Sinanovic E, Bennett B
PLoS One. 2017 Apr 20;12(4):e0174605. doi: 10.1371/journal.pone.0174605. eCollection 2017

Respondent understanding and user experience with the Asthma Daily Symptom Diary (ADSD), a novel patient-reported outcome measure
Nelsen L M, Gater A, Bonner N, Hall R, Staunton H, Eremenco S, on behalf of the Patient-Reported Outcome Consortium’s Asthma Working Group
American Thoracic Society 2017 International Conference: Washington, DC 19th-24th May 2017

Preliminary psychometric evaluation of the Asthma Daily Symptom Diary (ADSD)
Nelsen LM, Gater A, Coon C, Bonner N, Hall R, Staunton H, Coons SJ, on behalf of the Patient-Reported Outcome Consortium’s Asthma Working Group
Poster presented at the American Thoracic Society International Conference, Washington D.C.,USA, May 19-24, 2017

Characterizing the patient experience of asthma COPD overlap syndrome (ACOS) and COPD
Nelsen LM, Tolley C, Gater A, Panter C, Pascoe S, Lee LA
Poster presented at the American Thoracic Society International Conference, Washington D.C.,USA, May 19-24, 2017

Assessing asthma symptoms in adolescents and adults: Qualitative research supporting development of the asthma daily symptom diary
Gater A, Nelson L, Fleming S, Lundy J, Bonner N, Hall R, Marshall C, Staunton H, Krishnan J, Stoloff S, Schatz M, Haughney J on behalf of the Patient-Reported Outcome Consortium’s Asthma Working Group.
Value in Health 2016, 9:440-450

Exploring the qualitative experience of chest congestion with children and adults to develop patient-reported outcome items to self-assess symptoms of the common cold
Grant L, Marshall C, Burrows K, Khammo N, Albrecht H, Arbuckle R, Shea T
Poster presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 21st Annual International Meeting, Washington DC, USA, 21-25 May 2016

FP/FORM versus FP/SAL within clinical practice: An updated budget impact analysis in asthma
Farrington E, Saunders A, Heron L, Dunlop W
Adv Ther 2016. doi: 10.1007/s12325-016-0317-6. Epub 2016 Mar 26

Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis – a systematic review of global literature with focus on South Africa
Kastein-Hilka T, Abulfathi A, Rosenkranz B, Bennett B, Schwenkglenks M, Sinanovic E
Health Qual Life Outcomes 14,42, 2016

How to evaluate health-related quality of life and its association with medication adherence in pulmonary tuberculosis – Designing a prospective observational study in South Africa
Kastein-Hilka T, Rosenkranz B, Bennett B, Sinanovic E, Schwenkglenks M
Front. Pharmacology 31 May 2016

Structured review of health economic models in asthma
Enstone A, Price G, Viejo I, Dunlop W
Poster presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Vienna, Austria, 29th Oct-2nd Nov 2016

What represents a meaningful improvement in symptom-free days (SFD) and rescue-free days (RFD) for children? Perspectives from children and caregivers (Paediatric Asthma: Evaluation and Treatment)
Nelsen LM, Staunton H, Sully K, Khindri S, Svedsater H, Arbuckle R
Poster session presented at: ATS International Conference, San Francisco, USA, 13-18 May 2016

Development of a consensus statement for the definition, diagnosis, and treatment of acute exacerbations of idiopathic pulmonary fibrosis using the Delphi technique
Maher T, Whyte M, Hoyles R, Parfrey H, Ochiai Y, Mathieson N, Turnbull A, Williamson N, Bennett B
Advances in Therapy 2015;32:929-943

Patient reported burden of asthma on resource use and productivity across 11 countries in Europe
Fletcher M, Jha A, Dunlop W, Heron L, Wolfram V, Van der Molen T, Price D
Adv Ther. 2015 Apr;32(4):370-80. doi: 10.1007/s12325-015-0204-6. Epub 2015 Apr 26

The asthma working group: On the path to success
Nelsen L, Gater A, Papadopoulos E
Workshop presented at the 6th Annual Patient-Reported Outcome Consortium Workshop. Silver Spring, WA, April 29-30, 2015

The budget impact of an inhaler with improved features compared to Spiriva® Handihaler® for the management of chronic obstructive pulmonary disease (COPD) in the UK: Estimated impact on unscheduled healthcare costs and inhaler satisfaction
Nicolai J, Torvinen S, Howard DJ, Miles R, Greaney MH, Comberiati U, Plich A
Value in Health 2015 Nov;18(7):A497

The potential societal cost benefits of increasing patient satisfaction by using an inhaler with improved features compared to Spiriva® Handihaler® for the management of chronic obstructive pulmonary disease (COPD) in the UK
Nicolai J, Torvinen S, Miles R, Greaney MH, Howard DJ, Plich A
Value in Health 2015, Volume 18, Issue 7, A500

Burden of asthma on resource and productivity in 6 European countries
Fletcher M, Dunlop W, Jha A, Heron L, Van der Molen T, Price D
Eur Respir J 2014; 44(50):3816

Burden of asthma on resource and productivity in 6 European countries
Fletcher M, Dunlop W, Jha A, Heron L, Van der Molen T, Price D
Poster session presented at: European Respiratory Society Congress, Munich, Germany, 6-10 September 2014

Burden of asthma on resource and productivity in distinct patient clusters
Price D, Dunlop W, Jha A, Heron L, Van der Molen T, Fletcher M
Eur Respir J 2014; 44(58):3020

Burden of asthma on resource and productivity in distinct patient clusters
Price D, Dunlop W, Jha A, Heron L, Van der Molen T, Fletcher M
Poster session presented at: European Respiratory Society Congress, Munich, Germany, 6-10 September 2014

Developing a pediatric COA measurement strategy: A case study in asthma
Arbuckle R
Oral presentation presented at: 5th Annual Critical Path Institute Patient-Reported Outcome (PRO) Consortium Workshop, Silver Spring, USA, April 29-30, 2014

Development of the initial version of the Asthma Daily Symptom Diary
Mocarski M, Gater A, Fleming S, Nelsen LM, Coons SJ on behalf of the Patient-Reported Outcome Consortium’s Asthma Working Group (Asthma WG)
Poster presented at the American Thoracic Society International Conference San Diego, CA, USA, May 16-21, 2014

Device handling errors and the impact on quality of life and healthcare resource use in asthmatic patients
Jha A, Heron L, Marshall J, Dunlop W
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 17th Annual European Congress, Amsterdam, Netherlands, 8-12 November 2014

Identifying and measuring the core symptoms reported by persons with asthma: A review of the existing qualitative literature and patient-reported outcome measures
Nelsen LM, Gater A, Hall R, Coons SJ on behalf of the Patient-Reported Outcome Consortium’s Asthma Working Group (Asthma WG)
Poster presented at the American Thoracic Society International Conference San Diego, CA, USA, May 16-21, 2014

Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma
Dunlop W, Heron L, Fox G, Greaney M
Adv Ther 2013;30(10);933-944

Budget impact analysis of a new fixed-dose combination inhaler for a clinical commissioning group within the National Health Service in England
Dunlop W, Heron L, Fox G, Greaney M
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013

Validation of the COPD Population Screener (COPD-PS) and establishment of diagnostic cut-points in Japan
Inoue H, Momi H, Tsukuya G, Fukuyama S, Samukawa T, Kiyohara Y, Nakamura T, Crawford B, Ichinose M, Matsumoto K, Nakanishi N, on behalf of the Hisayama Pulmonary Physiology Study Group
Poster session presented at: American Thoracic Society , Philadelphia, USA, 17 – 22 May 2013

Patients’ experience of asthma control and clinical guidelines: Perspectives from a qualitative study
Rudell K, Hareendran A, Bonner N, Arbuckle R, Burbridge C, Abetz L
Respir Med 2012;106:909

Testing of a conceptual model of asthma in adolescents
Bright N, Maguire L, Arbuckle R, Tabberer M, Dale P
Value Health 2011;14:A497

Testing of a conceptual model of asthma in adolescents
Bright N, Maguire L, Arbuckle R, Tabberer M, Dale P
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011

Responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in exacerbations of COPD and chronic bronchitis
Monz BU, Sachs P, McDonald J, Crawford B, Nivens MC, Tetzlaff K
Respir Med 2010;104:534

Responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in patients with COPD and chronic bronchitis recovering from acute exacerbations
Tetzlaff K, Sachs P, McDonald J, Crawford B, Nivens C, Monz B
Poster session presented at: American Thoracic Society, San Diego, California, 15–20 May 2009